跳轉至內容
Merck
  • Targeting glycolysis: a fragment based approach towards bifunctional inhibitors of hLDH-5.

Targeting glycolysis: a fragment based approach towards bifunctional inhibitors of hLDH-5.

Chemical communications (Cambridge, England) (2010-08-03)
Adam D Moorhouse, Christian Spiteri, Pallavi Sharma, Mire Zloh, John E Moses
摘要

hLDH-5 has emerged as a promising target for anti-glycolytic cancer chemotherapy. Here we report a first generation of bifunctional inhibitors, which show promising activity against hLDH-5.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
草氨酸, ≥98%